Author: Yang, Jin-yu; Li, Min; Zhang, Cheng-liang; Liu, Dong
Title: Pharmacological properties of baicalin on liver diseases: a narrative review Cord-id: 9zdn9959 Document date: 2021_2_17
ID: 9zdn9959
Snippet: Baicalin is the main active component of Scutellaria baicalensis, widely used in traditional Chinese medicine thanks to its various pharmacological effects, such as anti-tumor, anti-inflammatory, and antibacterial properties, as well as cardiovascular, hepatic, and renal protective effect. Recently, the protective effects of baicalin on liver disease have received much more attention. Several studies showed that baicalin protects against several types of liver diseases including viral hepatitis,
Document: Baicalin is the main active component of Scutellaria baicalensis, widely used in traditional Chinese medicine thanks to its various pharmacological effects, such as anti-tumor, anti-inflammatory, and antibacterial properties, as well as cardiovascular, hepatic, and renal protective effect. Recently, the protective effects of baicalin on liver disease have received much more attention. Several studies showed that baicalin protects against several types of liver diseases including viral hepatitis, fatty liver disease, xenobiotic induced liver injury, cholestatic liver injury, and hepatocellular carcinoma, with a variety of pharmacological mechanisms. A comprehensive understanding of the mechanism of baicalin can provide a valuable reference for its clinical use, but up to now, no narrative review is available that summarizes the pharmacological effects of baicalin to clarify its potential use in the treatment of liver diseases. Therefore, this review summarizes the progress of baicalin research and the underlying mechanism in the treatment of various liver diseases, to promote further research and its clinical application. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s43440-021-00227-1.
Search related documents:
Co phrase search for related documents- action mechanism and additional evidence: 1, 2
- action mechanism and adjuvant treatment: 1, 2
- action mechanism and administered dose: 1, 2, 3, 4, 5, 6, 7
- action mechanism and administration week: 1
- action mechanism and adp ribose: 1, 2
- action mechanism and adp ribose polymerase: 1
- action mechanism and liver cirrhosis: 1, 2, 3
- action mechanism and liver concentration: 1
- action mechanism and liver damage: 1, 2, 3, 4
- action mechanism and liver disease: 1, 2, 3, 4
- action mechanism and liver disease development: 1
- action mechanism and liver increase: 1
- action mechanism and liver inflammation: 1, 2
- action mechanism and liver injury: 1, 2, 3, 4, 5
- action mechanism and liver lipid: 1
- action mechanism and liver target: 1
- action mechanism and liver transplantation: 1
- action mechanism and long history: 1, 2, 3, 4, 5
- action mechanism and low bioavailability: 1, 2
Co phrase search for related documents, hyperlinks ordered by date